FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2774624088> ?p ?o ?g. }

• W2774624088 endingPage "733" @default.
• W2774624088 startingPage "726" @default.
• W2774624088 abstract "Total body irradiation (TBI) has been included in standard conditioning for acute lymphoblastic leukemia (ALL) before hematopoietic cell transplantation (HCT). Non-TBI regimens have incorporated busulfan (Bu) to decrease toxicity. This retrospective study analyzed TBI and Bu on outcomes of ALL patients 18-60 years old, in first or second complete remission (CR), undergoing HLA-compatible sibling, related, or unrelated donor HCT, who reported to the Center for International Blood and Marrow Transplant Research from 2005 to 2014. TBI plus etoposide (25%) or cyclophosphamide (75%) was used in 819 patients, and intravenous Bu plus fludarabine (41%), clofarabine (30%), cyclophosphamide (15%), or melphalan (13%) was used in 299 patients. Bu-containing regimens were analyzed together, since no significant differences for patient outcomes were noted between them. Bu patients were older, with better performance status; took longer to achieve first CR and receive HCT; were treated more recently; and were more likely to receive peripheral blood grafts, antithymocyte globulin, or tyrosine kinase inhibitors. With median follow-up of 3.6 years for Bu and 5.3 years for TBI, adjusted 3-year outcomes showed treatment-related mortality Bu 19% versus TBI 25% (P = .04); relapse Bu 37% versus TBI 28% (P = .007); disease-free survival (DFS) Bu 45% versus TBI 48% (P = .35); and overall survival (OS) Bu 57% versus TBI 53% (P = .35). In multivariate analysis, Bu patients had higher risk of relapse (relative risk, 1.46; 95% confidence interval, 1.15 to 1.85; P = .002) compared with TBI patients. Despite the higher relapse, Bu-containing conditioning led to similar OS and DFS following HCT for ALL." @default.
• W2774624088 created "2017-12-22" @default.
• W2774624088 creator A5000083234 @default.
• W2774624088 creator A5001602966 @default.
• W2774624088 creator A5003367392 @default.
• W2774624088 creator A5006173110 @default.
• W2774624088 creator A5007647176 @default.
• W2774624088 creator A5007672289 @default.
• W2774624088 creator A5008405013 @default.
• W2774624088 creator A5008575399 @default.
• W2774624088 creator A5008762363 @default.
• W2774624088 creator A5009719497 @default.
• W2774624088 creator A5012489403 @default.
• W2774624088 creator A5016014484 @default.
• W2774624088 creator A5017044459 @default.
• W2774624088 creator A5017442411 @default.
• W2774624088 creator A5018065917 @default.
• W2774624088 creator A5019494133 @default.
• W2774624088 creator A5024492683 @default.
• W2774624088 creator A5026151069 @default.
• W2774624088 creator A5030768031 @default.
• W2774624088 creator A5031349996 @default.
• W2774624088 creator A5034264716 @default.
• W2774624088 creator A5034779401 @default.
• W2774624088 creator A5035520605 @default.
• W2774624088 creator A5036560661 @default.
• W2774624088 creator A5036856495 @default.
• W2774624088 creator A5038249770 @default.
• W2774624088 creator A5038261300 @default.
• W2774624088 creator A5039374832 @default.
• W2774624088 creator A5040369089 @default.
• W2774624088 creator A5041335047 @default.
• W2774624088 creator A5041526386 @default.
• W2774624088 creator A5042176968 @default.
• W2774624088 creator A5042915360 @default.
• W2774624088 creator A5042974681 @default.
• W2774624088 creator A5043585238 @default.
• W2774624088 creator A5045039087 @default.
• W2774624088 creator A5045176208 @default.
• W2774624088 creator A5045583767 @default.
• W2774624088 creator A5046436694 @default.
• W2774624088 creator A5048913229 @default.
• W2774624088 creator A5050880000 @default.
• W2774624088 creator A5052281366 @default.
• W2774624088 creator A5052875031 @default.
• W2774624088 creator A5057523501 @default.
• W2774624088 creator A5058557833 @default.
• W2774624088 creator A5060783496 @default.
• W2774624088 creator A5061188018 @default.
• W2774624088 creator A5061865992 @default.
• W2774624088 creator A5062103615 @default.
• W2774624088 creator A5062116571 @default.
• W2774624088 creator A5062691289 @default.
• W2774624088 creator A5065085606 @default.
• W2774624088 creator A5065360941 @default.
• W2774624088 creator A5066224233 @default.
• W2774624088 creator A5069441736 @default.
• W2774624088 creator A5069460930 @default.
• W2774624088 creator A5070043884 @default.
• W2774624088 creator A5070132319 @default.
• W2774624088 creator A5071407391 @default.
• W2774624088 creator A5074028658 @default.
• W2774624088 creator A5074515375 @default.
• W2774624088 creator A5082236040 @default.
• W2774624088 creator A5082616655 @default.
• W2774624088 creator A5082978958 @default.
• W2774624088 creator A5083504452 @default.
• W2774624088 creator A5084606047 @default.
• W2774624088 creator A5084915025 @default.
• W2774624088 creator A5085360755 @default.
• W2774624088 creator A5086380393 @default.
• W2774624088 creator A5087980705 @default.
• W2774624088 creator A5088486180 @default.
• W2774624088 creator A5088647781 @default.
• W2774624088 creator A5088962035 @default.
• W2774624088 creator A5089956110 @default.
• W2774624088 creator A5091083304 @default.
• W2774624088 creator A5091433944 @default.
• W2774624088 date "2018-04-01" @default.
• W2774624088 modified "2023-10-14" @default.
• W2774624088 title "Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia" @default.
• W2774624088 cites W1491993932 @default.
• W2774624088 cites W1530764705 @default.
• W2774624088 cites W1959073718 @default.
• W2774624088 cites W197482665 @default.
• W2774624088 cites W1977455450 @default.
• W2774624088 cites W1980501529 @default.
• W2774624088 cites W1985550470 @default.
• W2774624088 cites W1992011065 @default.
• W2774624088 cites W2005499564 @default.
• W2774624088 cites W2018956546 @default.
• W2774624088 cites W2021993787 @default.
• W2774624088 cites W2027025310 @default.
• W2774624088 cites W2035343180 @default.
• W2774624088 cites W2042888665 @default.
• W2774624088 cites W2044657518 @default.
• W2774624088 cites W2051239881 @default.
• W2774624088 cites W2063692775 @default.

• next